Distalmotion Secures Strategic Investment to Advance ASC Expansion of the DEXTER® Robotic Surgery System

This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capital. Distalmotion focuses on the growing need for a purpose-built robotic ...
Morningstar

Distalmotion Marks Patient Enrollment Milestones in General Surgery and Gynecology Clinical Trials for the DEXTER® Robotic Surgery System

Lausanne, Switzerland, Aug. 06, 2025 (GLOBE NEWSWIRE) -- Distalmotion today announced continued momentum in its clinical trial plans to support indication expansion of its DEXTER® Robotic Surgery ...
WDTN

Distalmotion Gains FDA 510(k) Clearance for Cholecystectomy, Further Advancing Access to Robotics in the Outpatient Setting with its DEXTER® Robotic Surgery System

Lausanne, Switzerland, May 28, 2025 (GLOBE NEWSWIRE) -- Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery in more sites of care, today announced that it has ...